Search Clinical Trials
585,889 trials
ID
Status
Phase
Title
Sponsor
NCT07604324
A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to Severe Atopic DermatitisNovartis PharmaceuticalsNot Yet RecruitingPhase 1
NCT07604324Not Yet Recruiting
Phase 1
A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Voluntee...Novartis Pharmaceuticals
NCT07600801
LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol BMassachusetts General HospitalNot Yet Recruiting
NCT07600801Not Yet Recruiting
—
LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-P...Massachusetts General Hos...
NCT07602712
Using Illusions to Boost Social CognitionHôpital le VinatierNot Yet RecruitingNot Applicable
NCT07602712Not Yet Recruiting
Not Applicable
Using Illusions to Boost Social CognitionHôpital le Vinatier
NCT07604649
TTM-Based Intervention for Weight Management Among High School Female StudentsUniversity of BaghdadNot Yet RecruitingNot Applicable
NCT07604649Not Yet Recruiting
Not Applicable
TTM-Based Intervention for Weight Management Among High School Female StudentsUniversity of Baghdad
NCT07600944
Comparison of the Pharmacokinetics (PK)and Pharmacodynamics (PD)Biosimilarity of Insulin Aspart Injections After Single-Dose Subcutaneous Administration to Healthy VolunteersZhuhai United Laboratories Co., Ltd.RecruitingNot Applicable
NCT07600944Recruiting
Not Applicable
Comparison of the Pharmacokinetics (PK)and Pharmacodynamics (PD)Biosimilarity of...Zhuhai United Laboratorie...
NCT07601204
Treatment of Recurrent/Metastatic Head and Neck CancerShanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.Not Yet RecruitingPhase 1
NCT07601204Not Yet Recruiting
Phase 1
Treatment of Recurrent/Metastatic Head and Neck CancerShanghai Chia Tai Tianqin...
NCT07605117
Isoinertial Training in Patients With COPDUniversidad Manuela BeltránNot Yet RecruitingNot Applicable
NCT07605117Not Yet Recruiting
Not Applicable
Isoinertial Training in Patients With COPDUniversidad Manuela Beltr...
NCT07604129
Transcranial Sonography and Machine Learning for Schizophrenia IdentificationTaizhou Second People's HospitalNot Yet Recruiting
NCT07604129Not Yet Recruiting
—
Transcranial Sonography and Machine Learning for Schizophrenia IdentificationTaizhou Second People's H...
NCT07601659
Prospective Italian Validation of SMS in Patients With Suspected Acute StrokeFondazione Policlinico Universitario Agostino Gemelli IRCCSNot Yet Recruiting
NCT07601659Not Yet Recruiting
—
Prospective Italian Validation of SMS in Patients With Suspected Acute StrokeFondazione Policlinico Un...
NCT07601360
Nature-based Outdoor Activities for Promoting Stress Resilience in EmployeesThe Chinese University of Hong Kong, ShenzhenCompletedNot Applicable
NCT07601360Completed
Not Applicable
Nature-based Outdoor Activities for Promoting Stress Resilience in EmployeesThe Chinese University of...
NCT07602049
Cryoablation Plus Camrelizumab for Advanced Soft Tissue SarcomaSun Yat-sen UniversityRecruitingPhase 2
NCT07602049Recruiting
Phase 2
Cryoablation Plus Camrelizumab for Advanced Soft Tissue SarcomaSun Yat-sen University
NCT07604207
Multi-organ Imaging of Microvascular and Metabolic FunctionMassachusetts General HospitalNot Yet RecruitingEarly Phase 1
NCT07604207Not Yet Recruiting
Early Phase 1
Multi-organ Imaging of Microvascular and Metabolic FunctionMassachusetts General Hos...
NCT07603440
Intravenous Thrombolysis With Tenecteplase Plus Thrombectomy Versus Thrombectomy Alone In Patients With A Large Ischemic Stroke: A Multicenter Randomized Controlled Trial (IVT-ALL-IN)Assistance Publique - Hôpitaux de ParisNot Yet RecruitingPhase 3
NCT07603440Not Yet Recruiting
Phase 3
Intravenous Thrombolysis With Tenecteplase Plus Thrombectomy Versus Thrombectomy...Assistance Publique - Hôp...
NCT07602582
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).Eli Lilly and CompanyNot Yet RecruitingPhase 3
NCT07602582Not Yet Recruiting
Phase 3
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAIL...Eli Lilly and Company
NCT07603869
Evaluation of Cardiovascular Risks Among the Participants of the EAPC Congress 2026European Society of CardiologyCompleted
NCT07603869Completed
—
Evaluation of Cardiovascular Risks Among the Participants of the EAPC Congress 2...European Society of Cardi...
NCT07604961
Short-Term Inspiratory Muscle Training and Aerobic Exercise in Women With COPDMehmet İsmail TOSUNCompletedNot Applicable
NCT07604961Completed
Not Applicable
Short-Term Inspiratory Muscle Training and Aerobic Exercise in Women With COPDMehmet İsmail TOSUN
NCT07601711
Sulbactam-Durlobactam in CRAB Infection: A Real-World Cohort StudySichuan Provincial People's HospitalRecruiting
NCT07601711Recruiting
—
Sulbactam-Durlobactam in CRAB Infection: A Real-World Cohort StudySichuan Provincial People...
NCT07602738
Evaluation of Liquorice Nanogel Versus Diode Laser as an Adjunctive Treatment for Patients With Periodontitis Stage Ⅲ.Al-Azhar UniversityCompletedPhase 3
NCT07602738Completed
Phase 3
Evaluation of Liquorice Nanogel Versus Diode Laser as an Adjunctive Treatment fo...Al-Azhar University
NCT07603882
Effects of Emotional Intelligence Training on Marital Satisfaction and Mental Health Among Married People in Dhaka CityUniversity of DhakaNot Yet RecruitingNot Applicable
NCT07603882Not Yet Recruiting
Not Applicable
Effects of Emotional Intelligence Training on Marital Satisfaction and Mental He...University of Dhaka
NCT07603427
Development of Biofunctional 3D-Printed Orthodontic Aligners With Antimicrobial and Remineralizing PropertiesUniversity of BaghdadNot Yet RecruitingNot Applicable
NCT07603427Not Yet Recruiting
Not Applicable
Development of Biofunctional 3D-Printed Orthodontic Aligners With Antimicrobial...University of Baghdad
Result Breakdown
Not yet recruiting13 (65%)
Completed4 (20%)
Recruiting3 (15%)
not_applicable8 (40%)
Not Specified5 (25%)
Phase 33 (15%)
Phase 12 (10%)
Phase 21 (5%)
Early Phase 11 (5%)